Cargando…

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

BACKGROUND: Tenofovir (TDF) is considered as the first line therapy for chronic hepatitis B. This study presents the results of TDF monotherapy in patients who failed previous nucleoside analogue treatment. METHODS: The study included 29 patients treated with TDF 245 mg once daily for 18 months afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozielewicz, Dorota, Halota, Waldemar, Wietlicka-Piszcz, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778152/ https://www.ncbi.nlm.nih.gov/pubmed/26612013 http://dx.doi.org/10.1007/s12072-015-9681-6

Ejemplares similares

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C
por: Domagalski, Krzysztof, et al.
Publicado: (2015)

Continuous up to 4 Years Entecavir Treatment of HBV-Infected Adolescents – A Longitudinal Study in Real Life
por: Pawłowska, Małgorzata, et al.
Publicado: (2016)

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
por: Lee, Hye Won, et al.
Publicado: (2016)

Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleoside-Analogue Naive Iranian Patients Treated for Chronic Hepatitis B
por: Bakhshizadeh, Fatemeh, et al.
Publicado: (2015)

Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study
por: Zhou, Jing, et al.
Publicado: (2017)

Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure
por: Lee, Cho I, et al.
Publicado: (2014)

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4
por: Domagalski, Krzysztof, et al.
Publicado: (2013)

HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy
por: Banerjee, Priyanka, et al.
Publicado: (2017)

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
por: Sano, Tomoya, et al.
Publicado: (2021)

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
por: Tütüncü, Emin Ediz, et al.
Publicado: (2017)

The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV
por: Waters, Laura, et al.
Publicado: (2021)

Virulence Factor Genes and Antimicrobial Susceptibility of Staphylococcus aureus Strains Isolated from Blood and Chronic Wounds
por: Budzyńska, Anna, et al.
Publicado: (2021)

Cumulative Effects of Particulate Matter Pollution and Meteorological Variables on the Risk of Influenza-Like Illness
por: Toczylowski, Kacper, et al.
Publicado: (2021)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
por: Yim, Hyung Joon
Publicado: (2016)

Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
por: Nagata, Naruhiko, et al.
Publicado: (2016)

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
por: Cho, Eun Ju, et al.
Publicado: (2015)

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
por: Jeon, Hee-Jeong, et al.
Publicado: (2017)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
por: Jung, Sang Kyung, et al.
Publicado: (2015)

HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
por: Pawłowska, M., et al.
Publicado: (2011)

Clostridium difficile infection in children hospitalized due to diarrhea
por: Dulęba, K., et al.
Publicado: (2013)

Nucleoside Analogues as Antibacterial Agents
por: Thomson, Jessica M., et al.
Publicado: (2019)

Effects of Nucleoside Analogue on Patients with Chronic Hepatitis B-Associated Liver Failure: Meta-Analysis
por: Xie, Feng, et al.
Publicado: (2013)

Fanconi’s Syndrome and Dementia in a Patient With Chronic Hepatitis B Taking Nucleoside/ Nucleotide Analogue
por: Ho, Cheuk Wah, et al.
Publicado: (2021)

Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients
por: Shang, Jin, et al.
Publicado: (2021)

Pediatric Enteroviral Central Nervous System Infections in Bialystok, Poland: Epidemiology, Viral Types, and Drivers of Seasonal Variation
por: Toczylowski, Kacper, et al.
Publicado: (2020)

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
por: Tsuruoka, Mio, et al.
Publicado: (2021)

Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study
por: Chang, Young, et al.
Publicado: (2021)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018)

Aminoribosylated Analogues of Muraymycin Nucleoside Antibiotics
por: Wiegmann, Daniel, et al.
Publicado: (2018)

Nucleoside analogues for the treatment of coronavirus infections
por: Pruijssers, Andrea J, et al.
Publicado: (2019)

Nucleoside analogues for the treatment of animal trypanosomiasis
por: Mabille, Dorien, et al.
Publicado: (2022)

Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
por: Lei, Jun, et al.
Publicado: (2013)

Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
por: Gerada, Jurgen, et al.
Publicado: (2013)

Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience
por: Kozielewicz, D., et al.
Publicado: (2011)

Nucleoside Analogues. Chemistry, Biology, and Medical Applications
por: Levinson, Barry L.
Publicado: (1980)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors
por: Alexandrova, Liudmila A., et al.
Publicado: (2022)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rkdu4mul5jbhfhq9163ucmc96v